Do analysts prefer JAGX or RVPH?

Reviva Pharmaceuticals has a consensus price target of $53.33, indicating a potential upside of 10,001.01%. Given Reviva Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Reviva Pharmaceuticals is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Reviva Pharmaceuticals 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Does the media refer more to JAGX or RVPH?

In the previous week, Jaguar Animal Health had 9 more articles in the media than Reviva Pharmaceuticals. MarketBeat recorded 10 mentions for Jaguar Animal Health and 1 mentions for Reviva Pharmaceuticals. Reviva Pharmaceuticals' average media sentiment score of 0.00 beat Jaguar Animal Health's score of -0.15 indicating that Reviva Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jaguar Animal Health 0 Very Positive mention(s) 0 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Reviva Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend JAGX or SNOA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Sonoma Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to JAGX or SNOA?

In the previous week, Jaguar Animal Health had 9 more articles in the media than Sonoma Pharmaceuticals. MarketBeat recorded 10 mentions for Jaguar Animal Health and 1 mentions for Sonoma Pharmaceuticals. Sonoma Pharmaceuticals' average media sentiment score of 0.00 beat Jaguar Animal Health's score of -0.15 indicating that Sonoma Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jaguar Animal Health 0 Very Positive mention(s) 0 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sonoma Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend JAGX or LEXX?

Lexaria Bioscience has a consensus price target of $22.50, indicating a potential upside of 598.76%. Given Lexaria Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Lexaria Bioscience is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Lexaria Bioscience 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer JAGX or NCNA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NuCana 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate JAGX or PULM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Pulmatrix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor JAGX or PULM?

In the previous week, Jaguar Animal Health had 9 more articles in the media than Pulmatrix. MarketBeat recorded 10 mentions for Jaguar Animal Health and 1 mentions for Pulmatrix. Pulmatrix's average media sentiment score of 0.00 beat Jaguar Animal Health's score of -0.15 indicating that Pulmatrix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jaguar Animal Health 0 Very Positive mention(s) 0 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Pulmatrix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Jaguar Animal Health (JAGX) Competitors

$34.46 +31.79 (+1,190.64%)

Closing price 09/22/2026 04:00 PM Eastern

Extended Trading

$36.46 +2.00 (+5.79%)

As of 09/22/2026 08:00 PM Eastern

Compare

JAGX vs. RVPH, SNOA, LEXX, NCNA, and PULM

Should you buy Jaguar Animal Health stock or one of its competitors? Jaguar Animal Health's main competitors and comparable companies include Reviva Pharmaceuticals (RVPH), Sonoma Pharmaceuticals (SNOA), Lexaria Bioscience (LEXX), NuCana (NCNA), and Pulmatrix (PULM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Jaguar Animal Health compare to Reviva Pharmaceuticals?

Jaguar Animal Health (NASDAQ:JAGX) and Reviva Pharmaceuticals (NASDAQ:RVPH) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Reviva Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat Reviva Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-187.88%	N/A	-131.45%
Reviva Pharmaceuticals	N/A	-391.58%	-119.08%

Reviva Pharmaceuticals has lower revenue, but higher earnings than Jaguar Animal Health. Reviva Pharmaceuticals is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	1.02	-$53.43M	-$248.88	N/A
Reviva Pharmaceuticals	N/A	N/A	-$19.86M	-$1.85	N/A

Jaguar Animal Health has a beta of -0.07, suggesting that its share price is 107% less volatile than the broader market. Comparatively, Reviva Pharmaceuticals has a beta of 0.5, suggesting that its share price is 50% less volatile than the broader market.

Reviva Pharmaceuticals has a consensus price target of $53.33, indicating a potential upside of 10,001.01%. Given Reviva Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Reviva Pharmaceuticals is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Reviva Pharmaceuticals	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Jaguar Animal Health had 9 more articles in the media than Reviva Pharmaceuticals. MarketBeat recorded 10 mentions for Jaguar Animal Health and 1 mentions for Reviva Pharmaceuticals. Reviva Pharmaceuticals' average media sentiment score of 0.00 beat Jaguar Animal Health's score of -0.15 indicating that Reviva Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jaguar Animal Health	0 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Reviva Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 63.2% of Reviva Pharmaceuticals shares are held by institutional investors. 0.2% of Jaguar Animal Health shares are held by company insiders. Comparatively, 8.9% of Reviva Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Reviva Pharmaceuticals beats Jaguar Animal Health on 11 of the 15 factors compared between the two stocks.

How does Jaguar Animal Health compare to Sonoma Pharmaceuticals?

Jaguar Animal Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

Jaguar Animal Health has a beta of -0.07, meaning that its share price is 107% less volatile than the broader market. Comparatively, Sonoma Pharmaceuticals has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market.

Sonoma Pharmaceuticals has a net margin of -10.33% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat Sonoma Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-187.88%	N/A	-131.45%
Sonoma Pharmaceuticals	-10.33%	-21.41%	-6.08%

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 2.0% of Sonoma Pharmaceuticals shares are owned by institutional investors. 0.2% of Jaguar Animal Health shares are owned by company insiders. Comparatively, 1.0% of Sonoma Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Sonoma Pharmaceuticals has higher revenue and earnings than Jaguar Animal Health. Sonoma Pharmaceuticals is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	1.02	-$53.43M	-$248.88	N/A
Sonoma Pharmaceuticals	$19.53M	0.32	-$3.17M	-$1.22	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sonoma Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Jaguar Animal Health had 9 more articles in the media than Sonoma Pharmaceuticals. MarketBeat recorded 10 mentions for Jaguar Animal Health and 1 mentions for Sonoma Pharmaceuticals. Sonoma Pharmaceuticals' average media sentiment score of 0.00 beat Jaguar Animal Health's score of -0.15 indicating that Sonoma Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jaguar Animal Health	0 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sonoma Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Sonoma Pharmaceuticals beats Jaguar Animal Health on 8 of the 13 factors compared between the two stocks.

How does Jaguar Animal Health compare to Lexaria Bioscience?

Jaguar Animal Health (NASDAQ:JAGX) and Lexaria Bioscience (NASDAQ:LEXX) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

Lexaria Bioscience has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat Lexaria Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-187.88%	N/A	-131.45%
Lexaria Bioscience	N/A	-174.93%	-143.89%

Jaguar Animal Health has a beta of -0.07, meaning that its stock price is 107% less volatile than the broader market. Comparatively, Lexaria Bioscience has a beta of 0.5, meaning that its stock price is 50% less volatile than the broader market.

12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 13.1% of Lexaria Bioscience shares are held by institutional investors. 0.2% of Jaguar Animal Health shares are held by company insiders. Comparatively, 8.4% of Lexaria Bioscience shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Jaguar Animal Health had 10 more articles in the media than Lexaria Bioscience. MarketBeat recorded 10 mentions for Jaguar Animal Health and 0 mentions for Lexaria Bioscience. Lexaria Bioscience's average media sentiment score of 0.00 beat Jaguar Animal Health's score of -0.15 indicating that Lexaria Bioscience is being referred to more favorably in the news media.

Company	Overall Sentiment
Jaguar Animal Health	Neutral
Lexaria Bioscience	Neutral

Lexaria Bioscience has a consensus price target of $22.50, indicating a potential upside of 598.76%. Given Lexaria Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Lexaria Bioscience is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Lexaria Bioscience	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Lexaria Bioscience has lower revenue, but higher earnings than Jaguar Animal Health. Lexaria Bioscience is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	1.02	-$53.43M	-$248.88	N/A
Lexaria Bioscience	$710K	7.48	-$11.90M	-$5.10	N/A

Summary

Lexaria Bioscience beats Jaguar Animal Health on 11 of the 16 factors compared between the two stocks.

How does Jaguar Animal Health compare to NuCana?

Jaguar Animal Health (NASDAQ:JAGX) and NuCana (NASDAQ:NCNA) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, Jaguar Animal Health had 10 more articles in the media than NuCana. MarketBeat recorded 10 mentions for Jaguar Animal Health and 0 mentions for NuCana. NuCana's average media sentiment score of 0.00 beat Jaguar Animal Health's score of -0.15 indicating that NuCana is being referred to more favorably in the news media.

Company	Overall Sentiment
Jaguar Animal Health	Neutral
NuCana	Neutral

12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 44.0% of NuCana shares are held by institutional investors. 0.2% of Jaguar Animal Health shares are held by insiders. Comparatively, 31.2% of NuCana shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

NuCana has lower revenue, but higher earnings than Jaguar Animal Health. NuCana is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	1.02	-$53.43M	-$248.88	N/A
NuCana	N/A	N/A	-$38.71M	-$3.81	N/A

NuCana has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat NuCana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-187.88%	N/A	-131.45%
NuCana	N/A	-41.90%	-33.69%

Jaguar Animal Health has a beta of -0.07, suggesting that its stock price is 107% less volatile than the broader market. Comparatively, NuCana has a beta of 2.23, suggesting that its stock price is 123% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NuCana	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

NuCana beats Jaguar Animal Health on 8 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to Pulmatrix?

Jaguar Animal Health (NASDAQ:JAGX) and Pulmatrix (NASDAQ:PULM) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

Pulmatrix has lower revenue, but higher earnings than Jaguar Animal Health. Pulmatrix is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	1.02	-$53.43M	-$248.88	N/A
Pulmatrix	$7.81M	0.79	-$5.16M	-$1.10	N/A

Jaguar Animal Health has a beta of -0.07, meaning that its share price is 107% less volatile than the broader market. Comparatively, Pulmatrix has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 11.8% of Pulmatrix shares are owned by institutional investors. 0.2% of Jaguar Animal Health shares are owned by insiders. Comparatively, 0.6% of Pulmatrix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pulmatrix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Jaguar Animal Health had 9 more articles in the media than Pulmatrix. MarketBeat recorded 10 mentions for Jaguar Animal Health and 1 mentions for Pulmatrix. Pulmatrix's average media sentiment score of 0.00 beat Jaguar Animal Health's score of -0.15 indicating that Pulmatrix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jaguar Animal Health	0 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pulmatrix	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pulmatrix has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat Pulmatrix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-187.88%	N/A	-131.45%
Pulmatrix	N/A	-125.65%	-95.19%

Summary

Pulmatrix beats Jaguar Animal Health on 7 of the 13 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

JAGX vs. The Competition

Export

Metric	Jaguar Animal Health	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$920K	$12.53B	$7.27B	$13.25B
Dividend Yield	N/A	2.63%	2.53%	13.00%
P/E Ratio	-0.14	789.92	274.30	25.85
Price / Sales	1.02	754.07	636.12	91.27
Price / Cash	N/A	86.22	76.31	52.02
Price / Book	-0.02	10.77	10.70	6.42
Net Income	-$53.43M	$2.81B	$3.49B	$360.08M
7 Day Performance	886.40%	3.73%	2.65%	2.79%
1 Month Performance	164.82%	0.16%	-1.73%	-2.48%
1 Year Performance	-96.73%	4.49%	18.68%	7.15%

Jaguar Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
JAGX Jaguar Animal Health	0.2784 of 5 stars	$34.46 +1,190.6%	N/A	-96.8%	$920K	$11.51M	N/A	47	Trading Halted High Trading Volume
RVPH Reviva Pharmaceuticals	1.6075 of 5 stars	$0.48 flat	$53.33 +11,011.1%	-91.4%	$6.29M	N/A	N/A	5	News Coverage Gap Up
SNOA Sonoma Pharmaceuticals	0.4228 of 5 stars	$1.28 -0.8%	N/A	-68.9%	$6.18M	$19.53M	N/A	180	News Coverage Positive News
LEXX Lexaria Bioscience	1.4799 of 5 stars	$3.21 -9.6%	$22.50 +600.9%	-84.1%	$5.87M	$710K	N/A	7
NCNA NuCana	0.3221 of 5 stars	$1.30 -1.5%	N/A	-66.8%	$5.49M	N/A	N/A	30	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:JAGX) was last updated on 9/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jaguar Animal Health (JAGX) Competitors

JAGX vs. RVPH, SNOA, LEXX, NCNA, and PULM

How does Jaguar Animal Health compare to Reviva Pharmaceuticals?

Summary

How does Jaguar Animal Health compare to Sonoma Pharmaceuticals?

Summary

How does Jaguar Animal Health compare to Lexaria Bioscience?

Summary

How does Jaguar Animal Health compare to NuCana?

Summary

How does Jaguar Animal Health compare to Pulmatrix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jaguar Animal Health (JAGX) Competitors

JAGX vs. RVPH, SNOA, LEXX, NCNA, and PULM

How does Jaguar Animal Health compare to Reviva Pharmaceuticals?

Is JAGX or RVPH more profitable?

Which has stronger valuation & earnings, JAGX or RVPH?

Which has more volatility and risk, JAGX or RVPH?

Do analysts prefer JAGX or RVPH?

Does the media refer more to JAGX or RVPH?

Do insiders & institutionals hold more shares of JAGX or RVPH?

Summary

How does Jaguar Animal Health compare to Sonoma Pharmaceuticals?

Which has more volatility & risk, JAGX or SNOA?

Is JAGX or SNOA more profitable?

Do institutionals and insiders believe in JAGX or SNOA?

Which has higher earnings & valuation, JAGX or SNOA?

Do analysts recommend JAGX or SNOA?

Does the media refer more to JAGX or SNOA?

Summary

How does Jaguar Animal Health compare to Lexaria Bioscience?

Is JAGX or LEXX more profitable?

Which has more volatility and risk, JAGX or LEXX?

Do institutionals & insiders hold more shares of JAGX or LEXX?

Does the media refer more to JAGX or LEXX?

Do analysts recommend JAGX or LEXX?

Which has stronger earnings & valuation, JAGX or LEXX?

Summary

How does Jaguar Animal Health compare to NuCana?

Does the media favor JAGX or NCNA?

Do insiders and institutionals believe in JAGX or NCNA?

Which has stronger valuation and earnings, JAGX or NCNA?

Is JAGX or NCNA more profitable?

Which has more volatility & risk, JAGX or NCNA?

Do analysts prefer JAGX or NCNA?

Summary

How does Jaguar Animal Health compare to Pulmatrix?

Which has better valuation and earnings, JAGX or PULM?

Which has more risk and volatility, JAGX or PULM?

Do institutionals and insiders believe in JAGX or PULM?

Do analysts rate JAGX or PULM?

Does the media favor JAGX or PULM?

Is JAGX or PULM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools